Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

JBMR Plus

Jacqueline Vanderpuye‐Orgle¹  Jorge Arellano¹  Jeffrey Lemay¹  Andreas Grauer¹  Andrea J Singer²  E Michael Lewiecki³  Amanda L Harmon⁴  Jesse D Ortendahl⁴  Michael S Broder⁴ 

[1] Amgen Inc Thousand Oaks CA USA;MedStar Georgetown University Hospital Washington DC USA;New Mexico Clinical Research & Osteoporosis Center Albuquerque NM USA;Partnership for Health Analytic Research, LLC Beverly Hills CA USA;

关键词: OSTEOPOROSIS;    FRACTURE PREVENTION;    FRACTURE RISK ASSESSMENT;    GENERAL POPULATION STUDIES;    HEALTH ECONOMICS;   

DOI  :  10.1002/jbm4.10192

来源: DOAJ

【 摘 要 】

ABSTRACT In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fracture burden in US women by modeling the expected demographic shift as well as potential policy changes. With the anticipated population aging and growth, annual fractures are projected to increase from 1.9 million to 3.2 million (68%), from 2018 to 2040, with related costs rising from $57 billion to over $95 billion. Policy‐driven expansion of case finding and treatment of at‐risk women could lower this burden, preventing 6.1 million fractures over the next 22 years while reducing payer costs by $29 billion and societal costs by $55 billion. Increasing use of osteoporosis‐related interventions can reduce fractures and result in substantial cost‐savings, a rare and fortunate combination given the current landscape in healthcare policy. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

【 授权许可】

Unknown